Provectus’s Substack
A clinical-stage biotechnology company developing immunotherapy medicines for different diseases based on a class of synthetic small molecule halogenated xanthenes, with lead molecule rose bengal sodium.
By registering you agree to Substack's Terms of Service, our Privacy Policy, and our Information Collection Notice